Dr. Gary Novack Attends Glaucoma Research Society Meeting in Cambridge
Dr. Gary Novack attended the biennial Glaucoma Research Society meeting in Cambridge, where researchers discussed innovative glaucoma research and the development of novel therapies.
Dr. Gary Novack Featured in The New York Times and UC Davis Health
Dr. Gary Novack was recently quoted in The New York Times and featured by UC Davis Health for his expert perspective on a nationwide recall of prescription eye drops. As a nationally recognized expert in ophthalmic drug development, clinical research, and regulatory science, Dr. Novack provided insight into the importance of quality standards, manufacturing oversight, and patient safety when […]
Dr. Novack Presents Clinical Research and FDA Insights at Napa Eye 2026
Dr. Novack presented multiple sessions at Napa Eye 2026, including research on novel ophthalmic medications and a lecture on FDA marketing authorization for ophthalmic drugs and devices.
Dr. Novack Attends ARVO 2026 Annual Meeting in Denver
Dr. Gary Novack attended the 2026 ARVO Annual Meeting in Denver, continuing a tradition of more than 40 years participating in one of ophthalmology’s leading scientific conferences. During the meeting, he presented research on FDA review times and a novel investigational treatment for pterygia while connecting with colleagues and collaborators in vision science.
Advancing Ophthalmic Innovation: Dr. Novack Presents Grand Rounds at the University of Louisville
Dr. Gary Novack presented Grand Rounds at the University of Louisville, discussing the translation of ophthalmic research into real-world therapies.
Advancing Glaucoma Care: Dr. Novack at the American Glaucoma Society Meeting
Dr. Novack attended the American Glaucoma Society Annual Meeting in Rancho Mirage, CA to explore the latest advances in glaucoma diagnosis, therapy, and research alongside leading experts in the field.
Dr. Novack Attends Glaucoma Research Foundation New Horizons Forum
Dr. Novack participated in the Glaucoma Research Foundation’s January 2026 New Horizons Forum, a collaborative gathering focused on emerging glaucoma therapies, diagnostics, and patient-driven innovation.
Dr. Novack meets with companies during JPMorgan Biomedical Conference
At the 2026 JPMorgan Healthcare Conference in San Francisco, Dr. Novack met with biomedical companies to advise PharmaLogic clients on regulatory and development issues affecting investigational ophthalmic therapeutics, amid renewed optimism across the life sciences industry.
Dr. Novack Lectures on Ophthalmic Drug Development at SNEC and SERI
Singapore, November 2025 — Dr. Novack delivered a lecture on ophthalmic drug development at the Singapore National Eye Centre (SNEC) and Singapore Eye Research Institute (SERI)…
Advancing Diabetic Vision Care: Dr. Novack at the Mary Tyler Moore Vision Initiative
Ann Arbor, November 2025 — Dr. Novack attended the Mary Tyler Moore Vision Initiative Annual Meeting, collaborating with leaders in ophthalmology and vision science to reduce diabetic vision loss…